Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gonadotropinomas.

Sushela S Chaidarun1, Anne Klibanski

  • 1Department of Medicine--Endocrine Division, The University of Virginia Health System, Charlottesville, Virginia 22908, USA.

Seminars in Reproductive Medicine
|January 22, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of thrombosis risk in patients undergoing purified and non-purified islet cell transplantation.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2025
Same author

Meeting Future Demands of Acute Care Through the Home Hospital Care Model.

Journal of healthcare management / American College of Healthcare Executives·2025
Same author

Quality of Life Following Total Pancreatectomy With Islet Autotransplantation: A Patient Experience Survey.

Pancreas·2024
Same author

Excess adiposity contributes to higher ambulatory central blood pressure and arterial stiffness in physically inactive young adults.

The Journal of sports medicine and physical fitness·2023
Same author

Low oxytocin levels are broadly associated with more pronounced psychopathology in anorexia nervosa with primarily restricting but not binge/purge eating behavior.

Frontiers in endocrinology·2023
Same author

Physiologic Transdermal Estradiol Replacement Mimics Effects of Endogenous Estrogen on Bone Outcomes in Hypoestrogenic Women with Anorexia Nervosa.

Nutrients·2022
Same journal

Understanding PGT-M: A Guide for Clinicians.

Seminars in reproductive medicine·2026
Same journal

Genetics in Reproduction.

Seminars in reproductive medicine·2026
Same journal

Genetics in Reproduction.

Seminars in reproductive medicine·2026
Same journal

Clinical Genetics in Reproductive Medicine: Variant Classification, Medically Actionable Genes, and Carrier Screening.

Seminars in reproductive medicine·2026
Same journal

Clinical Testing for Genetic Conditions.

Seminars in reproductive medicine·2026
Same journal

Genetics of Primary Ovarian Insufficiency.

Seminars in reproductive medicine·2026
See all related articles

Most clinically nonfunctioning pituitary adenomas are gonadotropinomas, often presenting with mass effects or incidentally. These tumors, though monoclonal, have an unknown pathogenesis and varied treatment responses.

Area of Science:

  • Endocrinology
  • Oncology
  • Molecular Biology

Background:

  • 80-90% of clinically nonfunctioning pituitary adenomas are gonadotropinomas.
  • Gonadotropinomas account for 40-50% of all pituitary macroadenomas.
  • Patients present with mass effects, hypogonadism, or are found incidentally.

Purpose of the Study:

  • To review the characteristics, classification, and therapeutic approaches for gonadotropinomas.
  • To discuss the molecular pathogenesis and potential therapeutic targets.

Main Methods:

  • Immunocytochemistry and molecular techniques for classification.
  • Review of clinical presentations and treatment outcomes.
  • Analysis of genetic factors like pituitary tumor transforming gene.

Related Experiment Videos

Main Results:

  • Gonadotropinomas classified as functioning (hormone-positive) or nonfunctioning (null cell).
  • Monoclonal origin but unknown pathogenesis; pituitary tumor transforming gene overexpression in two-thirds.
  • Transsphenoidal surgery is primary; radiosurgery shows promise for residual/recurrent tumors.

Conclusions:

  • Gonadotropinomas are a significant subset of pituitary macroadenomas.
  • Current therapies include surgery and radiosurgery, with limited success for medical treatments.
  • Further research into pathogenesis and novel therapies like gene therapy is warranted.